Sociedad Americana de Hirudoterapia

Clinical experience of Bushen Huoxue therapy in treatment of infertility due to endometriosis

Clinical experience report published in China Journal of Chinese Materia Medica (2019)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosSeguridad y control de infeccionesMa K et al. · Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica), 2019

Abstract

Endometriosis is a common and difficult gynecological disease. The incidence of endometriosis has been increasing year by year. Because endometriosis mostly occurs in childbearing age,it can cause persistent damage to the fertility of patients,and is an important cause of infertility. Although endometriosis is a benign disease,it has malignant behavior,and is easy for relapse and metastasis and difficult to treat in clinic. Early diagnosis,comprehensive evaluation,formulation of programs and timely treatment play an important role in protecting patients' fertility. The pathogenesis of endometriosis is still unclear in modern medicine. Drugs,surgery and assisted reproductive technology are the main therapies. The author has achieved a good efficacy in the long-term treatment of infertility due to endometriosis. She believes that the disease is caused by kidney deficiency and blood stasis. They are cause and effect to each other,which form a vicious circle. In view of the basic pathogenesis of kidney deficiency and blood stasis,we should make good use of the method of Bushen Huoxue,and emphasize the treatment by stages: promoting blood circulation and removing blood stasis,and treating diarrhea with purgative in the menstrual stage; nourishing kidney and blood,and regulating thoroughfare and conception vessels in the postmenstrual stage; warming kidney and supporting Yang,and dredging collaterals and hastening excretion in the interval stage;and tonifying kidney and spleen,and managing Qi and activating blood in the premenstruum stage. Leech is commonly adopted in clinic prescriptions to remove accumulation of persistent blood stasis and regulate mood,and combined with enema of traditional Chinese medicine,hot compress and other external therapies to enhance the curative effect.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsDrugs, Chinese HerbalEndometriosisFemaleHumansInfertility, FemaleMedicine, Chinese Traditional

Resumen

Report on Bushen Huoxue traditional Chinese medicine therapy for endometriosis-related infertility uses leech (medicinal Hirudo) in formulations to dissolve blood stasis as a key component of the regimen, combined with herbal enema and external therapies.

Por qué esto importa para la hirudoterapia

This article describes a traditional Chinese medicine (TCM) practitioner's clinical experience using Bushen Huoxue therapy for infertility caused by endometriosis, with treatment staged across the menstrual cycle. The abstract notes that leech is commonly adopted in clinical prescriptions to remove accumulation of persistent blood stasis and regulate mood, combined with herbal enema and hot compress as external therapies. The ASH relevance stems from documentation of medicinal leech use within TCM gynecological practice, reflecting a cultural tradition of leech-based intervention. However, the article provides no species identification, dosing details, preparation method, or outcome data specific to the leech component, the study design is unspecified in the abstract, and the focus is on endometriosis management rather than on hirudotherapy methodology or the leech secretome.

Citación

[Clinical experience of Bushen Huoxue therapy in treatment of infertility due to endometriosis].

Ma K et al. · Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica), 2019

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.